KALA News and Press, Kala Pharmaceuticals Inc. From 08/30/21

Vinco Ventures (NASDAQ:BBIG) +65%. Aterian (NASDAQ:ATER) +52%. Support.com (NASDAQ:SPRT) +45%. Affirm Holdings (NASDAQ:AFRM) +40% as Amazon to integrate pay-over-time into its cart Globalstar (NYSE:GSAT) +36% on report iPhone 13 may use satellite connectivity Katapult...

Today, we circle back and revisit a small biotech concern called Kala Pharmaceuticals. Like so many small biotech stocks, the shares have fallen back as biotech has retreated significantly from its February highs. We revisit the investment case on Kala Pharmaceuticals in the parag...

SPRT Stock Has Become The Cornerstone For Short Squeeze Penny Stock Breakouts This Quarter When penny stocks break out thousands of percentage points, traders take notice. This quarter, one little-known company, Support.com ( NASDAQ:SPRT ), began catching traction. While the company...

The following slide deck was published by Kala Pharmaceuticals, Inc. in conjunction with this event. For further details see: Kala Pharmaceuticals (KALA) Corporate Overview - Slideshow

Kala Pharmaceuticals, Inc. (KALA) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET Company Participants Niranjan Kameswaran - Senior Vice President of Strategy Mark Iwicki - Chairman, President & Chief Executive Officer Todd Bazemore - Chief Operating Officer Mary Reumuth - Chie...

-- EYSUVIS Prescriptions Increased by 93% Compared to First Quarter of 2021 -- -- Further Expanded Commercial Coverage for EYSUVIS to More Than 96 Million Lives -- -- Achieved $3.1 Million in Net Revenue in Second Quarter of 2021 -- -- Conference Call and Webcast at ...

WATERTOWN, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the foll...

WATERTOWN, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report second quarter 2021 fina...

-- EYSUVIS Added to OptumRx Commercial Formularies Effective May 21, 2021 -- -- Expands Total Commercial Coverage for EYSUVIS to More Than 88 Million Lives -- Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development...

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present at the Jefferies 2021 Virtual Healthcare Conference. Management is sche...